Contraceptive Drugs And Devices Market Report 2026

Contraceptive Drugs And Devices Market Overview

• Contraceptive Drugs And Devices market size has reached to $26.98 billion in 2025 • Expected to grow to $38.08 billion in 2030 at a compound annual growth rate (CAGR) of 7.1% • Growth Driver: Increase In Government Initiatives Fueling The Growth Of The Market Due To Rising Awareness Around Reproductive Health • Market Trend: Expansion Of Long-Acting Birth Control Options Through Innovative Vaginal Rings • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Contraceptive Drugs And Devices Market?

Contraceptive drugs and devices are medical products designed to prevent pregnancy through different methods. Drugs usually contain synthetic hormones that stop ovulation, thicken cervical mucus, or change the uterine lining. Devices include physical barriers that block sperm from reaching the egg and systems placed inside the uterus to prevent fertilization or implantation. The main products of contraceptive drugs and devices are contraceptive drugs and contraceptive devices. Contraceptive drugs are medications designed to prevent pregnancy by interfering with the normal process of ovulation, fertilization, or implantation. The various technologies involved include traditional methods, digital contraceptive apps, wearable devices, and long-acting reversible contraceptives (LARCs), while the different distribution channels comprise hospital pharmacies, retail pharmacies, clinics, online channels, public channels, non-governmental organizations, and others catering to end users such as males and females.

What Is The Contraceptive Drugs And Devices Market Growth Forecast?

The contraceptive drugs and devices market size is expected to see strong growth in the next few years. It will grow to $38.08 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to growth in digital health integration, rising demand for non-invasive contraceptive methods, expansion of telehealth-based prescriptions, increasing focus on male contraception research, supportive reproductive health policies. Major trends in the forecast period include rising adoption of long-acting reversible contraceptives, increasing use of hormonal combination therapies, growing demand for female-centric contraceptive solutions, expansion of over-the-counter contraceptive products, increasing acceptance of digital contraceptive platforms.

Global Contraceptive Drugs And Devices Market Segmentation

1) By Product: Contraceptive Drugs, Contraceptive Devices 2) By Technology: Traditional Methods, Wearable Devices, Long-Acting Reversible Contraceptives (LARCs) 3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channels And Non-Governmental Organizations, Other Distribution Channels 4) By End User: Male, Female Subsegments: 1) By Contraceptive Drugs: Oral Contraceptive Pills, Injectable Contraceptives, Contraceptive Patches, Vaginal Rings, Emergency Contraceptive Pills, Hormonal Implants 2) By Contraceptive Devices: Male Condoms, Female Condoms, Intrauterine Devices (IUDs), Diaphragms And Cervical Caps, Contraceptive Sponges, Sterilization Devices

What Is The Driver Of The Contraceptive Drugs And Devices Market?

The rising number of government initiatives about reproductive health is expected to propel the growth of the contraceptive drugs and devices market going forward. Government initiatives promote reproductive health through awareness, funding, and access to services. Government initiatives about reproductive health are growing due to the rising recognition of the need to address issues such as maternal health, family planning, and access to essential healthcare services, which are crucial for overall societal well-being and development. Government initiatives for contraceptive drugs and devices aim to increase access to affordable and effective family planning methods, ensuring that individuals can make informed choices about their reproductive health. For instance, in November 2024, according to the Australian Government Department of Foreign Affairs and Trade, an Australia-based government agency, Australia will allocate $56.8 million to a new initiative aimed at promoting sexual and reproductive health and rights in Southeast Asia. Therefore, the rising number of government initiatives about reproductive health is driving the expansion of the contraceptive drugs and devices industry.

Key Players In The Global Contraceptive Drugs And Devices Market

Major companies operating in the contraceptive drugs and devices market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co Inc., Bayer AG, Viatris Inc., Teva Pharmaceuticals Ltd, Lupin Limited, CooperSurgical Inc., Mithra Pharmaceuticals, DKT International, Fuji Latex Co Ltd, Agile Therapeutics Inc., Cupid Limited, Veru Inc., Eskag Pharma Pvt. Ltd., Biosante Pharmaceuticals Inc., HLL Lifecare Limited, Afaxys Inc., The Female Health Company (FC2), Mayer Laboratories Inc., Daré Bioscience Inc.

Global Contraceptive Drugs And Devices Market Trends and Insights

Major companies operating in the contraceptive drugs and devices market are developing innovative products, such as contraceptive vaginal rings, to enhance user convenience and expand long-acting contraceptive options. A contraceptive vaginal ring is a flexible, hormone-releasing device inserted into the vagina to prevent pregnancy by inhibiting ovulation. For instance, in October 2023, Xiromed LLC, a US-based pharmaceutical company, launched EnilloRing, a soft, flexible, contraceptive vaginal ring designed to be inserted into the vagina, where it steadily releases a combination of etonogestrel (a progestin) and ethinyl estradiol (an estrogen) over three weeks to prevent ovulation. As a bioequivalent generic to NuvaRing, it offers women a convenient, discreet, and cost-effective monthly birth control option that eliminates the need for daily dosing while maintaining the same safety, efficacy, and tolerability profile as the branded version.

What Are Latest Mergers And Acquisitions In The Contraceptive Drugs And Devices Market?

In March 2024, Insud Pharma SL, a Spain-based pharmaceutical company, acquired Viatris Inc.'s women's healthcare business for an undisclosed amount. With this acquisition, Insud Pharma strengthens its presence in emerging markets by acquiring two manufacturing facilities in India and enhancing its ability to supply oral contraceptives to global public health institutions. Viatris Inc. is a US-based pharmaceutical and healthcare company that focuses on oral and injectable contraceptives.

Regional Insights

North America was the largest region in the contraceptive drugs and devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Contraceptive Drugs And Devices Market?

The contraceptive drugs and devices market consists of sales of hormonal pills, emergency contraceptives, contraceptive implants, intrauterine devices (IUDs), condoms, patches, and vaginal rings. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Contraceptive Drugs And Devices Market Report 2026?

The contraceptive drugs and devices market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the contraceptive drugs and devices industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.